Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index
- PMID: 22325254
- PMCID: PMC3366166
- DOI: 10.1016/j.jpeds.2011.12.050
Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index
Abstract
Objective: We sought to assess the glucose disposition index using an oral glucose tolerance test (OGTT; oDI) compared with the glucose disposition index measured from the combination of the euglycemic-hyperinsulinemic and hyperglycemic clamps (cDI) in obese pediatric subjects spanning the range of glucose tolerance.
Study design: Overweight/obese adolescents (n = 185) with varying glucose tolerance (87 normal, 54 impaired, 31 with type 2 diabetes, and 13 with type 1 diabetes) completed an OGTT and both a hyperinsulinemic-euglycemic and a hyperglycemic clamp study. Indices of insulin sensitivity and β-cell function were calculated, and 4 different oDI estimates were calculated as the products of insulin and C-peptide-based sensitivity and secretion indices.
Results: Mirroring the differences across groups by cDI, the oDI estimates were greatest in normal glucose tolerance adolescents and lowest in type 2 diabetes mellitus and obese with type 1 diabetes mellitus adolescents. The insulin-based oDI estimates correlated with cDI overall (r ≥ 0.74, P < .001) and within each glucose tolerance group (r ≥ 0.40, P < .001). Also, oDI and cDI predicted 2-hour OGTT glucose similarly.
Conclusions: The oDI is a simple surrogate estimate of β-cell function relative to insulin sensitivity that can be applied to obese adolescents with varying glucose tolerance in large-scale epidemiological studies where the applicability of clamp studies is limited due to feasibility, cost, and labor intensiveness.
Copyright © 2012 Mosby, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Comment in
-
The oral disposition index: a valuable estimate of β-cell function in obese youth.J Pediatr. 2012 Jul;161(1):3-4. doi: 10.1016/j.jpeds.2012.02.013. Epub 2012 Mar 30. J Pediatr. 2012. PMID: 22464745 No abstract available.
References
-
- Lewy V, Danadian K, Arslanian SA. Early metabolic abnormalities in adolescents with polycystic ovarian syndrome (PCOS) Pediatr Res. 1999;45:93a. - PubMed
-
- Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA-Journal of the American Medical Association. 2010;303:242–9. - PubMed
-
- Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocr Metab. 2002;87:1017–23. - PubMed
-
- Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M, et al. Type 2 diabetes in the young: The evolving epidemic - the International Diabetes Federation Consensus Workshop. Diabetes Care. 2004;27:1798–811. - PubMed
-
- Ahren B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol. 2004;150:97–104. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
